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Abstract   25 
It has been proposed that enzymes can associate into complexes (metabolons) that increase 26 
the efficiency of metabolic pathways by channelling substrates between enzymes. Metabolons 27 
may increase flux by increasing local concentration of intermediates, decreasing the 28 
concentration of enzymes needed to maintain a given flux, directing the products of a pathway 29 
to a specific subcellular location or minimise the escape of reactive intermediates.  Metabolons 30 
can be formed by relatively loose non-covalent protein-protein interaction, anchorage to 31 
membranes and (in bacteria) by encapsulation of enzymes in protein-coated 32 
microcompartments.  Evidence that non-coated metabolons are effective at channelling 33 
substrates is scarce and difficult to obtain. In plants there is strong evidence that small 34 
proportions of glycolytic enzymes are associated with the outside of mitochondria and are 35 
effective in substrate channelling.  More recently, synthetic metabolons, in which enzymes are 36 
scaffolded to synthetic proteins or nucleic acids, have been expressed in micro-organisms and 37 
these provide evidence that scaffolded enzymes are more effective than free enzymes for 38 
metabolic engineering.  This provides experimental evidence that metabolons may have a 39 
general advantage and opens the way to improving the outcome of metabolic engineering in 40 
plants by including synthetic metabolons in the toolbox.           41 
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Introduction 49 
 50 
The concept of “synthetic biology” embraces the idea of redesigning organisms from the 51 
ground up. It is enabled by the standardisation of DNA parts and experimental procedures that 52 
allows automation, reliable output measurements and robust biological engineering; the 53 
thorough characterisation of DNA parts so that their behaviour in a given context is 54 
predictable; and the further modularisation of these parts into devices that perform well-55 
defined functions. This latter concept allows further abstraction in which this information (e.g. 56 
DNA sequence, part or device data) is hidden thereby reducing the observable details allowing 57 
the researcher to focus on a few key concepts at a time (Freemont and Kitney, 2012).  As an 58 
example, selectable marker cassettes may be considered devices - nowadays it is unusual for 59 
the researcher to look in detail at what resides within these markers, we know they confer 60 
resistance to a given antibiotic or herbicide and for most of the time that is all that is required. 61 
In applying this approach across the board the parts and devices can be used and re-used to 62 
provide predictable, highly controlled levels of gene expression to produce regulatory circuits 63 
or novel metabolic pathways with predictable outcomes. This approach often requires 64 
transformation with multiple genes and most of the examples are currently from readily 65 
transformed microorganisms. The effort is aided by improved gene cloning technology and the 66 
decreasing cost of synthesising genes de novo. In bacteria, the ability to produce novel 67 
organisms with streamlined genomes, in which the various patches and fixes installed during 68 
evolution are replaced or streamlined, has emerged (Gibson et al., 2010) and will allow 69 
production of more efficient vehicles for production of useful end products.  This review will 70 
not address the nuts and bolts of DNA manipulation and the problems of expressing multiple 71 
transgenes in plants at controlled levels in specific cell types but will rather focus on proteins 72 
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and enzymes and how these might be designed and manipulated more effectively for plant 73 
metabolic engineering.  Metabolic engineering is well established in microorganisms and this is 74 
where synthetic biology approaches first emerged.  There are metabolic engineering success 75 
stories in plants for example expression of carotene biosynthesis genes in rice grain to create 76 
“golden rice”, multi-vitamin corn (Naqvi et al., 2009) and altered seed lipids  (DellaPenna, 2001; 77 
Mayer et al., 2008; Napier and Graham, 2010; Ruiz-Lopez et al., 2014; Ye et al., 2000). 78 
Metabolic engineering could also be employed to improve crop yield by manipulating 79 
photosynthesis, starch synthesis and production of osmolytes and defensive compounds. 80 
However, the result of over-expression of a few judiciously chosen enzymes is often 81 
disappointing due to lack of understanding of metabolic regulation and possible toxicity of end 82 
products.  Therefore use of approaches that go beyond enzyme over-expression should be 83 
considered. Improved photosynthesis, nutrient use and stress resistance would not only 84 
increase the efficiency of plant production but may also allow for the use of plants as chemical 85 
factories.  Such synthetic biology approaches are emerging in microbial metabolic engineering 86 
and the purpose of this review is to consider one of these approaches- the creation of synthetic 87 
enzyme complexes (metabolons) and assess their potential application in plants.   88 
 89 
Metabolons, microcompartments and metabolic channelling 90 
 91 
The term “metabolon” was coined by Srere to describe complexes of enzymes that carry out 92 
sequential reactions (Srere, 1987, 2000).  This definition is potentially wide and could include 93 
stable assemblies of enzymes that carry out complex or vectorial series of reactions such as 94 
ribosomes (protein synthesis), proteasomes (protein degradation), photosynthetic and 95 
respiratory electron transport complexes, ATP synthase, mammalian and fungal fatty acid 96 
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synthase, polyketide synthases, non-ribosomal peptide synthases and cellulosomes (cellulose 97 
degradation complexes in bacteria) (Hyeon et al., 2013).  These multi-protein complexes carry 98 
out series of reactions that require intermediates to be shepherded (channelled) precisely. The 99 
relatively complex series of reactions required for fatty acid synthesis are located in a dimeric 100 
multifunctional fatty acid synthase in mammals and fungi (Voet and Voet, 2004).  Similarly, 101 
polyketide synthases and non-ribosomal peptide synthases consist of several proteins each 102 
with multiple active sites, allowing synthesis of complex molecules such as antibiotics (Khosla 103 
et al., 1999).  In the case of the pyruvate dehydrogenase complex, tryptophan synthase and 104 
carbamoyl phosphate synthetase, intermediates are effectively channelled between active 105 
sites (Voet and Voet, 2004). Apart from these examples of stable or close complexes, where 106 
intermediates are directly shuttled between active sites, the existence of functional 107 
metabolons based on loose or transitory enzyme-enzyme interactions is a matter of 108 
controversy. The proposed advantages of metabolons include increasing the concentration of 109 
intermediates at the active sites of sequential enzymes and minimizing escape of reactive or 110 
potentially toxic intermediates (Jørgensen et al., 2005; Moller, 2010; Srere, 1987; Sweetlove 111 
and Fernie, 2013; Winkel, 2004).  These possibilities are illustrated in the review by Chen and 112 
Silver (2012). The general argument against metabolons providing an advantage is that 113 
metabolites diffuse too quickly relative to reaction rates and cell size for there to be a 114 
significant concentration of intermediates in the vicinity of the complex.   While demonstrating 115 
that complexes are likely to occur in vitro is relatively easy, assessing their functionality is much 116 
more difficult. To assess the significance of proposed complexes based on protein-protein 117 
interaction methods such as pull-downs (e.g. TAP-tagging), surface plasmon resonance and 118 
yeast2-hybrid assays, it is necessary to demonstrate that association occurs in vivo. This is 119 
probably best done with fluorescently-tagged proteins using techniques such as Förster 120 
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resonance energy transfer (FRET) and bimolecular fluorescence complementation (BIFC) (Ohad 121 
et al., 2007). However, methods with a higher throughput such as yeast 2-hybrid or pull-downs 122 
followed by protein identification using mass spectrometry are ideal for initial screening. There 123 
are numerous examples of proposed metabolons in animals and microorganisms (Chen and 124 
Silver, 2012; Srere, 1987).  Recent examples include glycolysis (Araiza-Olivera et al., 2013; 125 
Puchulu-Campanella et al., 2013), the TCA cycle (Meyer et al., 2011; Mitchell, 1996; Velot et al., 126 
1997), amino acid biosynthesis (de Cima et al., 2012; Hutson et al., 2011; Islam et al., 2007), 127 
acyl ester biosynthesis  (Jiang and Napoli, 2013) and melanin biosynthesis (Sugumaran et al., 128 
2000). While most of the examples involve protein-protein interactions (with the possible 129 
inclusion of a membrane-located anchoring proteins), other methods of complex formation 130 
have been identified, for example association of glycolytic enzymes with F-actin (Araiza-Olivera 131 
et al., 2013) or targeting of enzymes to lipid droplets (Jiang and Napoli, 2013). In plants, 132 
plastogobuli – lipid inclusions in chloroplasts- have enzymes of isoprenoid biosynthesis and 133 
chlorophyll degradation associated with them (Lundquist et al., 2012; Nacir and Bréhélin, 2013) 134 
and so could organise enzymes that metabolise lipophilic substrates.   Despite the relatively 135 
abundant evidence for physical association of enzymes into metabolons, more definitive 136 
evidence that pathway intermediates are effectively channelled (for example from isotope 137 
dilution studies) is very rare (Graham et al., 2007), leading to scepticism about their function.       138 
 139 
Given the increasing number of metabolons proposed in other organisms, it is not surprising 140 
that the evidence for association of enzymes into complexes in plants is accumulating.  A 141 
number of reviews cover this evidence (Jørgensen et al., 2005; Sweetlove and Fernie, 2013; 142 
Winkel, 2004).  Pathways, or parts of pathways, in which enzymes are associated in complexes 143 
include glycolysis and various biosynthesis pathways (polyamines, flavonoids, 144 
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phenylpropanoids, cyanogenic glycosides, sporopollenin, long chain alkanes, cyanogenic 145 
glycosides and indole acetic acid). The references and evidence for the existence of enzyme 146 
complexes and their functional significance are shown in Table 1 while other examples of 147 
possible secondary metabolite metabolons have been reviewed elsewhere (Jørgensen et al., 148 
2005).  Mining the high throughput Arabidopsis yeast 2-hybrid data should indicate further 149 
pathways in which enzymes form complexes (Arabidopsis Interactome Mapping Consortium, 150 
2011; Zhang et al., 2010). It is possible that the search for metabolons in plants could also be 151 
guided by the conservation of protein-protein interactions across phylogenetic groups.  Clearly, 152 
the demonstration of enzyme complexes does not prove that pathway flux is improved or that 153 
potentially toxic intermediates are confined. Evidence that this benefit occurs for some 154 
pathways was discussed in the previous section. In plants, this level of evidence is sparse. In 155 
the case of association of glycolytic enzymes with the outer mitochondrial membrane, isotope 156 
dilution experiments have shown that addition of unlabelled intermediate has little effect on 157 
the specific activity of products produced from a labelled precursor (Giege et al., 2003; Graham 158 
et al., 2007). This is key evidence that indicates not only are the enzymes spatially organised, 159 
but that there is also a degree of direct substrate channelling between them. In the case of 160 
glycolysis, it is important to note that only a small proportion of the enzymes locate to the 161 
mitochondria and therefore the effect is local.       162 
 163 
The idea that enzymes of the Calvin-Benson cycle may also aggregate into metabolons has 164 
been around for some time (Anderson et al., 2006) but their existence remains unproven. The 165 
Calvin-Benson cycle however does provide an alternative paradigm for regulation of central 166 
metabolism by protein complexes. A well-documented multi-enzyme complex exists between 167 
two, non-sequential Calvin-Benson cycle enzymes, phosphoribulokinase (PRK) and 168 
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glyceraldehyde 3-phosphate dehydrogenase (GAPDH) that is mediated by the small chloroplast 169 
protein CP12 (Wedel and Soll, 1998; Wedel et al., 1997). When PRK and GAPDH are aggregated 170 
within this complex they are far less active and more susceptible to allosteric inhibition than 171 
their unbound forms. The PRK/GAPDH/CP12 complex, which is present in darkened leaves, is 172 
capable of almost instantaneous dissociation (activation) upon illumination, and similar, rapid 173 
association (deactivation) upon transfer to darkness (Howard et al., 2008). This process, 174 
dependent upon the activity of the photosynthetic electron transport chain and mediated by 175 
thioredoxin (Howard et al., 2008; Marri et al., 2009) allows swift, dynamic 176 
activation/inactivation of enzyme activity in response to environmental changes. This 177 
mechanism provides an alternative function for synthetic metabolic protein complexes in line 178 
with the aims of making smarter metabolically engineered pathways that are responsive to 179 
cellular demands (Zhang et al., 2012). Despite the lack of strong evidence for a more general 180 
Calvin-Benson cycle metabolons, recent detailed flux analysis using 13CO2 labelling in 181 
Arabidopsis thaliana provides evidence for discrete pools of metabolites, a feature that could 182 
indicate some degree of metabolite channelling within the stroma (Szecowka et al., 2013). 183 
 184 
Bacterial microcompartments (metabolosomes/enterosomes) consist of enzymes that are 185 
encapsulated in self-assembling protein coats forming particles that are of the order of 100 nm 186 
in diameter.  They are found in various bacteria and generally contain pathways that have 187 
reactive or toxic intermediates, for example in ethanol, ethanolamine and propanediol 188 
utilisation (Kerfeld et al., 2010). Cyanobacterial carboxysomes, which are part of the carbon 189 
dioxide concentrating mechanism of these organisms, are a well-known example (Kerfeld et al., 190 
2010; Rae et al., 2013). They contain ribulose bisphosphate carboxylase-oxygenase (RuBisCO) 191 
and carbonic anhydrase (CA). The coat proteins form suitably charged pores that allow ingress 192 
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of substrates (RuBP and bicarbonate). Within the carboxysome, CO2 release from bicarbonate 193 
is catalysed by CA and then RuBisCO catalyses the carboxylation of RuBP to form 194 
phosphoglyceric acid, the first product of the Calvin-Benson cycle. The localised release of CO2 195 
in the carboxysome outcompetes the oxygenase reaction of RuBisCO which otherwise results 196 
in “wasteful” photorespiration (Bauwe et al., 2012; Maurino and Peterhansel, 2010). Protein-197 
coated microcompartments could therefore provide another route to controlling or improving 198 
metabolic flux and their introduction into C3 chloroplasts, along with bicarbonate transporters 199 
has been suggested as an approach to decreasing photorespiration (Price et al., 2013).  200 
  201 
Synthetic metabolons    202 
The previous discussion indicates that while a number of metabolons have been proposed, the 203 
evidence that they function in improving metabolic flux is scarce.  Perhaps the most direct way 204 
to determine the utility of metabolons is to introduce them into cells and assess their effect on 205 
flux or product formation. The possibility of constructing synthetic enzymes complexes has 206 
been discussed in a number of recent reviews (Boyle and Silver, 2012; Lee et al., 2012).  While 207 
there are a number of ways that synthetic enzyme complexes could be assembled, the first 208 
approach to have been employed is to assemble enzymes onto a synthetic scaffold protein 209 
using protein interaction domains.  This makes use of the reasonably high affinity and specific 210 
interactions between protein interaction modules and their peptide ligands derived from 211 
various scaffolding and signalling systems. A gene encoding a synthetic scaffold protein 212 
containing the protein interacting domains separated by spacer sequences in the required 213 
order and stoichiometry is synthesised. The enzymes are tagged with the corresponding 214 
peptide ligands. This approach has been used to scaffold three enzymes of the mevalonic acid 215 
biosynthesis pathway in E. coli (Dueber et al., 2009). A synthetic scaffold protein was 216 
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constructed carrying three high affinity protein interaction domains: the Src homology domain 217 
3 (SH3) from the mouse Crk adapter protein (Wu et al., 1995) the PDZ domain from the -218 
syntrophin protein from mouse (Schultz et al., 1998) and the GTPase-binding domain (GBD) 219 
from the neuronal Wiskott-Aldrich syndrome protein (N-WASP) (Kim et al., 2000). The three 220 
enzymes were tagged with their cognate peptide ligands. When expressed together, the 221 
ligands reversibly bind to the scaffold protein and form a complex. Scaffolding increased 222 
product titre 77-fold compared to unscaffolded enzymes- and with lower overall protein 223 
expression (HMG-CoA intermediate is toxic) (Dueber et al). Similar approaches with a 3 step 224 
biosynthesis pathway for glucaric acid from glucose in E. coli yielded a 5 fold increase in yield of 225 
product (Moon et al., 2010).  Similarly, in yeast, scaffolding 4-coumarate:CoA ligase and 226 
stilbene synthase increased the yield of resveratrol by 5-fold compared to unscaffolded 227 
enzymes (Wang and Yu, 2012). For this two enzyme pathway, a fusion protein was also tested 228 
but was less effective than scaffolded enzymes perhaps because of folding problems (Zhang et 229 
al., 2006). 230 
 231 
Scaffolding has also been shown to work in vitro.  In this case, triose phosphate isomerase, 232 
aldolase and fructose 1,6-bisphosphatase where scaffolded in vitro resulting in a 38 to 48-fold 233 
increase in reaction rate for scaffolds free in solution or bound to cellulose respectively (You 234 
and Percival Zhang, 2013). This example used a system based on the cellulosome complex from 235 
various cellulose degrading bacteria. The cellulosome consists of a scaffoldin protein containing 236 
dockerin domains to which proteins containing cohesin domains bind. In this example, the 237 
enzymes were tagged with three dockerin domains and the scaffold was constructed from the 238 
three respective cohesin domains with an N-terminal carbohydrate binding domain. The three 239 
dockerin/cohesin domains originated from three different cellulolytic microorganisms.    240 
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 241 
The factors underpinning increased product titre of these synthetic scaffold complexes have 242 
been investigated.  Variation in linker length and protein positioning affect yield and support 243 
the conclusion that increased enzyme proximity is a key factor (Lee et al., 2012).  Also, it is 244 
evident that enzyme stoichiometry within the metabolons is important, revealing an issue for 245 
conventional metabolic engineering where enzyme over-expression levels are often not 246 
precisely controlled.   Although the experiments with synthetic metabolons reveal an 247 
advantage, the explanation for this is not obvious.  It has been argued that the product of an 248 
enzyme is likely to diffuse away very quickly along its concentration gradient because typical 249 
enzyme reaction rates are much slower than diffusion  (Sweetlove and Fernie, 2013) so that 250 
proximity might not provide significantly increased substrate concentration.  The actual 251 
diffusion rates in the cytoplasm are therefore important.  Evidence from the mobility of 252 
fluorescently labelled glucose in E. coli cells suggests that it diffuses ~10 times more slowly in 253 
vivo (50 µm2 s-1)  than in water (400 µm2 s-1), reflecting the intense  macromolecular crowding 254 
of the cytoplasm (Mika et al., 2010).  Proteins, being larger, diffuse more slowly: 3-10 µm2 s-1 in 255 
the cytoplasm. Evidence for the existence of diffusion gradients would be difficult to produce if 256 
enzymes are evenly distributed in the cytoplasm but examples where a small molecule is 257 
produced in a localised manner suggest that concentration gradients can exist.  Firstly, it is 258 
well-known that localised release of Ca2+ within cells leads to localised high concentration 259 
microdomains (Berridge, 2006). Secondly, hydrogen peroxide is produced locally in some cells 260 
by plasma membrane NADPH oxidase, an example being  growing pollen tubes where a 261 
gradient of hydrogen peroxide forms. Visualised by a ROS sensitive fluorescent probe, 262 
hydrogen peroxide concentration is highest at the tip (Potocký et al., 2007). Therefore, relative 263 
to the rate of production and breakdown, diffusion is apparently not fast enough to equilibrate 264 
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hydrogen peroxide concentration throughout the cell.  It is also likely that the diffusion rate of 265 
small molecules will depend on their chemical properties (for example propensity to interact 266 
with proteins) as well as size.   Interestingly, in a modification of the in vitro scaffolding of 267 
triose phosphate isomerase, aldolase and fructose 1,6-bisphosphatase, replacement of the 268 
original aldolase with another of lower specific activity removed the advantage of scaffolding 269 
(You and Zhang, 2013).  This observation shows that the specifics of enzyme kinetics are 270 
critical.   Modelling of the system is needed to clarify the important factors, particularly to 271 
determine if increased local substrate concentration is generally important.  Because of 272 
relatively rapid diffusion, the size of the complex may also be critical: bigger complexes are 273 
predicted to capture and use more of the intermediates (Lee et al., 2012). These authors 274 
suggested 100 nm would be ideal for the scaffolded mevalonate pathway. In this system, since 275 
some of the enzymes are multimeric, they could bind to multiple scaffolds producing a larger 276 
complex.  Another potentially important effect could be control of pathway branch points and 277 
competition between different pathways for the same intermediates. In the latter case, a 278 
higher proportion of the product of a scaffolded enzyme might be passed on to its neighbour 279 
than to an unscaffolded competitor. Scaffolding also provides a potential means to control 280 
branch points by manipulating protein-protein interactions by signal molecules. As an example, 281 
one can envisage that binding sites for pathway products or precursors could be included in a 282 
synthetic scaffold such that binding causes conformational changes that alter the distance 283 
between the scaffolded enzymes or cause dissociation of the complex. This would be 284 
analogous to FRET-based glucose sensors (Jones et al., 2013). There is already evidence that 285 
metabolic status can affect the conformation of the ER-bound flavonoid biosynthesis 286 
metabolons in plants, potentially directing intermediates down one branch of the pathway or 287 
another (Crosby et al., 2011). It is very unlikely that any of the current examples have 288 
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introduced the more extreme form of substrate channelling shown by enzyme complexes such 289 
as tryptophan synthetase where intermediates pass through tunnels lined with amino acid 290 
residues of appropriate charge and never enter the external water.  Introduction of direct 291 
channelling would require more sophisticated protein engineering to create and orientate 292 
channels.  These examples provide evidence that synthetic scaffolds can improve flux and 293 
product formation even though the mechanisms are not entirely clear and even counter-294 
intuitive given the fast diffusion rates of small molecules (Lee et al., 2012; Sweetlove and 295 
Fernie, 2013). Nevertheless, the results provide a rationale for the natural occurrence of 296 
metabolons. 297 
 298 
Since proteins can bind to nucleic acids with high affinity and in a nucleotide sequence-specific 299 
manner (e.g. transcription factors), they could also act as scaffolds for enzymes.  This has been 300 
demonstrated in E. coli for introduced resveratrol, 1,2-propanediol and mevalonic acid 301 
biosynthetic pathways (Conrado et al., 2012). In this example, each enzyme was fused with a 302 
DNA binding zinc finger domain. These were expressed in E. coli along with a plasmid 303 
containing multiple copies of each Zn finger binding nucleotide sequence.  Evidence that the 304 
enzymes assembled on the plasmid was obtained and, in each case, product formation was 305 
increased over a random scaffold control. Interestingly, the increase in mevalonic acid was 306 
much less than the 77-fold reported for protein scaffolds (Dueber et al., 2009). Problems with 307 
plasmids will include sufficient copy number to scaffold available protein and supercoiling. This 308 
method is currently not applicable to plants but assembly on RNA scaffolds is a possibility. RNA 309 
molecules (aptamers) that fold into specific conformations and with sequences that can 310 
specifically bind small molecules and proteins could be used as scaffolds (Delebecque et al., 311 
2011).  Application of this approach to hydrogen production in E. coli using ferredoxin and 312 
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hydrogenase tagged with adapter proteins that bind to specific RNA aptamers resulted in 313 
stable scaffolded protein/RNA complexes and increased the rate of hydrogen production by up 314 
to 48 fold compared to unscaffolded.  Clearly, in this case, electron transfer from reduced 315 
ferredoxin to hydrogenase requires very close proximity, but as with protein scaffolds, there is 316 
no reason to suppose this approach would not work for other pathways. A potential problem 317 
with expression of RNA in sufficient amounts is stability. However, advantages are the complex 318 
3D structures that RNA can form and the possibility of designing specific protein binding 319 
aptamers. This could extend to the possibility of adding riboswitch-like control mechanisms in 320 
which small molecules also bind to the RNA scaffold and change its conformation. This could 321 
change the distance between scaffolded enzymes and modulate flux according to the 322 
concentration of an “allosteric” controlling molecule.          323 
 324 
Bacterial microcompartments (BMCs) provide inspiration for another approach to creating 325 
synthetic metabolons in which enzymes are encapsulated in self assembling protein shells 326 
(Frank et al., 2013; Retterer and Simpson, 2012).  This provides a physical diffusion barrier to 327 
pathway intermediates thus improving local concentration of intermediates, but has the 328 
requirement that the shell proteins provide pores for substrate to enter and product to leave.  329 
Although the structure of some BMCs is complex, recent work shows that they can be 330 
assembled in host bacteria and protein cargo can be encapsulated. Thus, the shell proteins 331 
from the propanediol utilization BMC from Citrobacter freundii can be expressed in E. coli to 332 
form empty structures (Parsons et al., 2010).  Expression of a carboxysome operon from 333 
Halothiobacillus neapolitanus, including pore protein, coat protein, CA and Rubisco in E. coli 334 
produced functional carboxysomes (Bonacci et al., 2012).  Significantly, the Salmonella enterica 335 
ethanolamine utilization (eut) shell protein expressed in E. coli assembles to form a polyhedral 336 
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structure.  These structures could be loaded with enhanced green fluorescent protein fused to 337 
an appropriate N-terminal signal sequence (Choudhary et al., 2012). Therefore, in principle, it 338 
should be possible to encapsulate multiple enzymes in synthetic BMCs.  Utility in metabolic 339 
engineering will depend not only on successful assembly and targeting of enzymes but also on 340 
understanding how to include entry and exit pores for substrate and product.  Clearly, the way 341 
is open to attempt assembly of microcompartments in plant cells and the introduction of 342 
carboxysome-like compartments into chloroplasts to improve carboxylation efficiency is a 343 
potential target.  Viral coat proteins offer another source of self assembling 344 
microcompartments.  Empty cowpea mosaic virus particle (termed empty virus-like particles, 345 
eVLPs) can be assembled in plants by expressing the virus coat precursor protein and a 346 
protease that cleaves it into the final form (Saunders and Lomonossoff, 2013). Other 347 
approaches to assembling synthetic metabolons could include targeting enzymes to the 348 
cytoskeleton (Araiza-Olivera et al., 2013) or using membrane anchored proteins as in the 349 
naturally-occurring flavonoid and glycolytic metabolons (Crosby et al., 2011; Graham et al., 350 
2007) that tether the pathway enzymes. In this way metabolons could be targeted to specific 351 
membranes perhaps directing transport of products into specific subcellular compartments 352 
(e.g. the vacuole for storage of potentially toxic products). Positioning might also allow a 353 
pathway to efficiently access substrates emanating from an organelle.  354 
Microcompartmentation and localisation of signalling complexes is achieved by anchoring 355 
complexes to lipid rafts. These are specialised membrane microdomains that are rich in 356 
cholesterol and sphingolipids into which GPI-anchored proteins insert thereby fostering close 357 
proximity of proteins (Simons and Ikonen, 1997). The NADPH oxidase (NOX) complex which 358 
includes NOX and various regulatory proteins that control the oxidative burst is an example 359 
from animals (Shao et al., 2003) that may also operate in plants (Borner et al., 2003).   360 
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 361 
Looking to the future: synthetic metabolons in plants. 362 
 363 
The potential advantages of metabolons and microcompartments include increased flux (or 364 
less enzyme needed to maintain a given flux), containment of potentially toxic or biologically 365 
active intermediates, control over enzyme stoichiometry and the ability to control 366 
branchpoints and thereby direct metabolism.  Based on the experience of the introduction of 367 
metabolons into microorganisms, it is clear that a similar strategy should be considered as part 368 
of the plant metabolic engineering toolbox. Since secondary metabolism provides clear 369 
examples of enzyme complexes (Jørgensen et al., 2005) it is  likely that metabolons will be of 370 
particular value in production of exotic compounds in plants. Pathways that have exotic or 371 
reactive intermediates may benefit from channelling. In the future, metabolons could 372 
incorporate switching mechanisms as proposed for flavonoid biosynthesis  (Crosby et al., 2011) 373 
in which metabolic status is sensed causing association or disassociation of the complexes 374 
(Michener et al., 2012). It is interesting that, as well as associating into complexes, the enzymes 375 
of the flavonoid biosynthesis pathway are under tight transcriptional control suggesting that 376 
control of enzyme concentrations well as complex formation is important in this pathway.  The 377 
appearance of an array of genetically-encoded fluorescent metabolite sensors also opens the 378 
way to monitoring metabolism in cells in “real time” and, in conjunction with flux analysis using 379 
labelled substrates, will allow improved understanding of metabolic control and bottlenecks 380 
(Berg et al., 2009; Hung et al., 2011; Jones et al., 2013; Michener et al., 2012; Tantama et al., 381 
2011).   382 
 383 
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The cyanobacterial carboxysome (and algal pyrenoids) are archetypal metabolons which bring 384 
about CO2 concentration at the active site of RuBisCO by bringing carbonic anhydrase (CA) and 385 
RuBisCO into close proximity along with a supply of bicarbonate. Therefore, one possible way 386 
to improve photosynthesis would be to introduce mechanisms inspired by these systems into 387 
C3 crop plants (Price et al., 2013).  This approach could include introduction of bicarbonate 388 
pumps into the chloroplast envelope and arrangement of RuBisCO and CA into scaffolded 389 
complexes or even into synthetic carboxysomes. The latter approach should be possible given 390 
the recent demonstrations that simple microcompartments can assemble in a host cell and 391 
that protein cargo can be included (Choudhary et al., 2012; Lee et al., 2012). The key trick is to 392 
ensure that the shell proteins contain suitable pores for transport of RuBP and bicarbonate 393 
into the microcompartment and 3-PGA out while trapping the released CO2 effectively.   An 394 
alternative strategy is to explore the utility of scaffolding RuBisCO and CA so that CO2 is 395 
released in close proximity to RuBisCO, thus decreasing oxygenase activity (Singleton, Harmer, 396 
Porter and Smirnoff, unpublished results; http://magic.psrg.org.uk).  This approach has 397 
theoretical problems because the inherently slow catalytic rate of RuBisCO prevents effective 398 
use of CO2 before it diffuses away.  Other synthetic biology approaches to improving 399 
photosynthesis such as expression of carboxysome-like structures in chloroplasts may also 400 
emerge in the near future.  401 
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Table 1.  Evidence for metabolons and metabolic channeling in plants. The nature of the 
evidence is as follows: A, immunogold localisation; B, physical association (co-
purification/pulldown/yeast 2-hybrid); C, co-localisation of fluorescently tagged proteins in vivo 
(e.g. FRET/BIFC); D, flux measurements.  
 
Pathway Evidence References 
Glycolysis B, C, D (Giege et al., 2003; Graham et al., 2007) 
Calvin-Benson cycle A, D (Anderson et al., 2006; Suss et al., 1993; 
Szecowka et al., 2013) 
Phenylpropanoids B, C, D (Achnine et al., 2004; Bassard et al., 2012; 
Rasmussen and Dixon, 1999) 
Flavonoids B,C (Crosby et al., 2011) 
Spermine/spermidine  B  (Panicot et al., 2002) 
Indole acetic acid B (Müller and Weiler, 2000) 
Long chain alkanes B, C (Bernard et al., 2012) 
Sproropollenin B, C (Lallemand et al., 2013)  
Glyoxylate cycle B (Beeckmans et al., 1994) 
Dhurrin (cyanogenic glycoside) B, C  (Nielsen et al., 2008) 
 
 
 
 
 
